Abstract
Pretreatment with U74500A (up to 0.65 mg/100 g) failed to affect gastric lesions induced by 100% EtOH gavage in Sprague-Dawley rats. Topical application of U74500A did not reduce lesions induced by 40% EtOH inex vivo gastric chamber preparations. However, pretreatment of rats with U74500A (0.65 g/100 gper os) reduced the incidence and severity of experimental duodenal ulcer induced by cysteamine HCl, and duodenal ulcer induced by cysteamine-HCl plus GABA. These results show U74500A to have powerful and specific antiduodenal ulcer actions. Pharmacologic analysis of organ-bath preparations of the small intestine show this compound to reduce intestinal contractility to applied cholinergic and serotonergic agonists. However, relaxations induced by electrical or nicotinic ganglionic stimulation were unaffected. U74500A itself caused concentrationdependent contractions.
Similar content being viewed by others
References
Anderson DK, Braughler JM, Hall ED, Waters TR, McCall JM, Means ED: Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury. J Neurosurg 69:562–567, 1988
Hall ED, Yonkers PA, McCall JM, Braughler JM: Effects of the 21-Aminosteroid U74006F on experimental head injury in mice. J Neurosurg 68:456–461, 1988
Braughler JM, Pregenzer RL, Chase RL, Duncan LA, Jacobsen EJ, McCall JM: Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 262(22):10438–10440, 1987
Braughler JM, Hall ED, Jacobsen EJ, McCall JM, Means ED: The 21-aminosteroids: Potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemia. Drugs of the Future 14(2):143–152, 1989
Hall ED, Pazara KE: Effects of novel 21-aminosteroid antioxidants on postischemic neuronal degeneration.In Cerebrovascular Diseases. MD Ginsberg, WD Dietrich (eds). New York, Raven Press, 1989, pp 387–391
Braughler JM, Burton PS, Chase RL, Pregenzer JF, Jacobsen EJ, Vandoornik FJ, Tustin JM, Ayer DE, Bundy GL: Novel membrane localized iron chelators as inhibitors of iron-dependent lipid peroxidation. Biochem Pharmacol 37(20):3853–3860, 1988
Robert A, Nezamis JE, Lancaster C, Badalamenti JN: Cysteamine-induced duodenal ulcers. A new model to test antiulcer agents. Digestion 11:199–214, 1974
Szabo S: Animal models of human disease. Duodenal ulcer disease. Animal model: Cysteamine-induced acute and chronic duodenal ulcer in the rat. Am J Pathol 93:273–276, 1978
Krantis A, Nicholson M: Augmentation of cysteamineinduced ulceration of rat duodenum by systemically administered γ-aminobutyric acid (GABA). Dig Dis Sci 34(8):1211–1216, 1989
Morris GP, Williamson TE, Hynna TT: Prostaglandins and mucosal defensive mechanisms. Can J Gastroenterol 4(3):95–107, 1990
Takeuchi K, Nishiwaki H, Okabe S: Role of local motility changes in the pathogenesis of duodenal ulcers induced by cysteamine in rats. Dig Dis Sci 32:295–304, 1987
Ohe K, Miura Y, Taoka Y, Okada Y, Miyoshi A: Cysteamine-induced inhibition of mucosal and pancreatic alkaline secretion in rat duodenum. Dig Dis Sci 33(3):330–337, 1988
McIntosh C, Bakich V, Trotter T, Kwok YN, Nichimura E, Pederson R, Brown J: Effect of cysteamine on secretion of gastrin and somatostatin from the rat stomach. Gastroenterology 86:834–838, 1984
Wallace JL, Morris GP, Krausse EJ, Greaves SE: Reduction by cytoprotective agents of ethanol-induced damage to the rat gastric mucosa: A correlated morphological and physiological study. Can J Physiol. Pharmacol 60:1686–1699, 1982
Pihan G, Regillo C, Szabo S: Free radicals and lipid peroxidation in ethanol-or aspirin-induced gastric mucosal injury. Dig Dis Sci 32:1395–1401, 1987
Walen A: Antacids and anticholinergics in the treatment of duodenal ulcer. Clin Gastroenterol 13(2):473–499, 1984
Brooks FP: The pathophysiology of peptic ulcer disease. Dig Dis Sci 30(11):15S-29S, 1985
Szabo S: Biology of disease: Pathogenesis of duodenal ulcer disease. Lab Invest 51:121–147, 1984
Tanaka H, Takeuchi K, Okabe S: Role of accumulated gastric content in the pathogenesis of cysteamine-and mepirizole-induced duodenal ulcers in the rat. J Intern Med 732 (228 suppl):69–75, 1990
Poulsen SS, Raaberg L, Therkelsen K, Skov Olsen P, Kirkegaard P: Effect of antisecretory agents and vagotomy on healing of “chronic” cysteamine-induced duodenal ulcers in rats. Dig Dis Sci 31:753–759, 1986
Tanaka H, Takeuchi K, Okabe S, Murakami M: Pathogenesis of the earliest epithelial cell damage induced by mepirizole and cysteamine in the rat duodenum. Jpn J Pharmacol 51:509–519, 1989
Tanaka H, Takeuchi K, Okabe S: The relationship of intraduodenal pH and delayed gastric emptying in duodenal ulceration induced by mepirizole or cysteamine in rats. Jpn J Pharmacol 51:483–492, 1989
Poulsen SS, Kirkegaard P, Skov Olsen P, Jensen KK, Christiansen J: Role of delayed gastric emptying in the pathogenesis of cysteamine-induced duodenal ulcer in the rat. Scand J Gastroenterol 17:325–330, 1982
Szabo S, Pihan G, Gallagher GT, Brown A: Role of local secretory and motility changes in the pathogenesis of experimental duodenal ulcer. Scand J Gastroenterol 19(suppl 92): 106–111, 1984
Groves WG, Schlosser JH, Mead FD: Acid hypersecretion and duodenal ulcers produced by cysteamine in rats. Res Commun Chem Pathol Pharmacol 9:523–534, 1974
Kirkegaard P, Poulsen SS, Loud FB, Halse C, Christiansen J: Cysteamine-induced duodenal ulcers induced and acid secretion in the rat. Scand J Gastoenterology 15:621–624, 1980
Pihan G, Kline TJ, Hollenberg NK, Szabo S: Duodenal ulceregens cysteamine and proprionitride induce gastroduodenal motility alterations in the rat. Gastroenterology 88:989–997, 1985
Takeuchi K, Nishiwaki H, Okabe S: Role of local motility changes in the pathogenesis of duodenal ulcers induced by cysteamine in rats. Dig Dis Sci 32:295–304, 1987
Livingston EH, Howard TJ, Garrick TR, Passaro EP, Jr, Guth PH: Strong gastric contractions cause mucosal ischemia. Am J Physiol 260:G524-G530, 1991
Qvist G, Dormandy J, Brown C, Slome D, Scott GBD: The experimental production of gastric ulcers by induced muscle spasm. Br J Surg 61:259–263, 1974
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Krantis, A., Harding, R.K., McKay, A.E. et al. Effects of compound U74500A in animal models of gastric and duodenal ulceration. Digest Dis Sci 38, 722–729 (1993). https://doi.org/10.1007/BF01316806
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01316806